Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
limitations in staff and resources
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Tonsillectomy is commonly described as one of the most painful procedures that an adult can undergo. This study's aim is to evaluate if pre-operative oral hydration has an impact in reducing post-operative pain, nausea and vomiting, and opioid medication use after adult tonsillectomies. Participants will be randomized to a low, medium and high fluid intake groups and will record fluid intake on the day before surgery. After surgery, participants will record their pain and nausea at timepoints up to 7 days post-operative. Medication use will be recorded up to the first post-operative follow-up visit with their physician.
Common indications for adult tonsillectomy include tonsillar hypertrophy, obstructive sleep apnea, and chronic tonsillitis. Although there are many studies looking into how best to prevent and treat post-operative pain and nausea, there are very few that give recommendations to the patients pre-operatively. This study's aim is to evaluate if pre-operative oral hydration has an impact in reducing post-operative pain, nausea and vomiting after adult tonsillectomies. If pre-operative hydration can reduce the pain associated with the procedure, then this could also be an adjunct to help reduce the amount of narcotic pain medication that is required.
The goal of this study is to evaluate if the amount of pre-operative oral hydration can reduce the amount of pain and nausea/vomiting in patients undergoing adult tonsillectomies. This study will be measuring post-operative pain and nausea scores at several points after the adult tonsillectomy procedure for participants that have consumed different amounts of clear fluid in the 24 hours leading up to their nothing by mouth (NPO) status. Participants will be randomized to one of three categories of preoperative fluid: 0.5 - 1.5 Liters (L), 1.5 - 3 L, and 3 - 4.5 L, which will correlate to the low, medium and high fluid intake groups, respectively. Participants will be given a 1000 mL measuring water bottle that they can use to accurately record their fluid consumption in the 24 hours prior to their pre-operative NPO status. The fluid consumption that they record will include all liquids (i.e., water, flavored water, juice, coffee, tea, soda, milk, alcohol). They will be asked to keep a record of the volume of caffeinated beverage versus un-caffeinated beverages.
After surgery the participants will be given a form to record their pain and nausea scores. Participants will record their pain and nausea by using two separate 10-point scales at 7 different points after the procedure. These scores will be measured immediately after surgery, and at 4 hours, 8 hours, 24 hours, 72 hours, 5 days and 7 days postoperative. This form, along with a count of opioid medication used, will be retuned to the physician at the first post-operative follow-up visit.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Low fluid intake | Experimental | 0.5 L - 1.5 L fluid intake in the 24 hours prior to NPO status for surgery |
|
| Medium fluid intake | Experimental | 1.5 L - 3 L fluid intake in the 24 hours prior to NPO status for surgery |
|
| High fluid intake | Experimental | 3 L - 4.5 L fluid intake in the 24 hours prior to NPO status for surgery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oral water and clear liquids | Other | Measured oral intake of fluids prior to tonsillectomy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain 8 hours postoperative | Participant reported pain on a Likert scale from 0-10, where 0=no pain and 10= worst pain possible. | 8 hours postoperative |
| Nausea 4 hours postoperative | Participant reported nausea on a Likert scale from 0-10, where 0=no nausea and 10 = worst nausea possible. | 4 hours postoperative |
| Measure | Description | Time Frame |
|---|---|---|
| Pain postoperative | Participant reported pain on a Likert scale from 0-10, where 0=no pain and 10= worst pain possible. | up to 7 days postoperative |
| Nausea postoperative | Participant reported nausea on a Likert scale from 0-10, where 0=no nausea and 10 = |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Matthew Farrugia, DO | Beaumont Health - Farmington Hills | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000072836 | Surgical Wound |
| D010149 | Pain, Postoperative |
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D014867 | Water |
| ID | Term |
|---|---|
| D006878 | Hydroxides |
| D000468 | Alkalies |
| D007287 | Inorganic Chemicals |
| D000838 | Anions |
| D007477 |
Not provided
Not provided
3 group parallel comparison, non-blinded, interventional
Not provided
Not provided
Not provided
Not provided
|
| up to 7 days postoperative |
| Narcotic pain medication use immediately following surgery | Opioid pain medication administered in Post-Anesthesia Care Unit (PACU) in morphine equivalents | 4 hours |
| Nausea medication use immediately following surgery | Oral anti-nausea medication administered in Post-Anesthesia Care Unit (PACU) | 4 hours |
| Narcotic pain medication use after discharge | Opioid pain medication used after discharge in morphine equivalents | up to 14 days postoperative |
| Nausea medication use after discharge | Oral anti-nausea medication (4 mg zofran) used after discharge | up to 14 days postoperative |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009422 | Nervous System Diseases |
| Ions |
| D004573 | Electrolytes |
| D010087 | Oxides |
| D017601 | Oxygen Compounds |